| Literature DB >> 33392386 |
Christos Kourek1, Manal Alshamari1, Georgios Mitsiou1, Katherina Psarra2, Dimitrios Delis1, Vasiliki Linardatou1, Theodoros Pittaras3, Argyrios Ntalianis4, Costas Papadopoulos5, Niki Panagopoulou1, Ioannis Vasileiadis6, Serafim Nanas1, Eleftherios Karatzanos1.
Abstract
BACKGROUND: Vascular endothelial dysfunction is an underlying pathophysiological feature of chronic heart failure (CHF). Endothelial progenitor cells (EPCs) are also impaired. The purpose of the study was to assess the effect of a cardiac rehabilitation (CR) program on the increase of EPCs at rest and on the acute response after maximal exercise in patients with CHF and investigate whether there were differences between two exercise training protocols and patients of NYHA II and III classes.Entities:
Keywords: Acute maximal cardiopulmonary exercise testing; Cardiac rehabilitation program; Chronic heart failure; Endothelial progenitor cells; High-intensity interval training
Year: 2020 PMID: 33392386 PMCID: PMC7772790 DOI: 10.1016/j.ijcha.2020.100702
Source DB: PubMed Journal: Int J Cardiol Heart Vasc ISSN: 2352-9067
Demographic characteristics for patients with CHF enrolled in the cardiac rehabilitation program, as well as for each exercise training group and NYHA class group. Except ejection fraction and type of CHF in NYHA group comparison, not any other differences were observed between groups (p > 0.05).
| Demographic characteristics | All patients | Exercise Groups | NYHA class Groups | ||
|---|---|---|---|---|---|
| HIIT Group | COM Group | NYHA II | NYHA III | ||
| Number of patients (N) | 44 | 21 | 23 | 34 | 10 |
| Gender ( | 35 / 9 | 17 / 4 | 18 / 5 | 27 / 7 | 8 / 2 |
| Age (years)a | 56 ± 10 | 55 ± 11 | 57 ± 9 | 56 ± 10 | 55 ± 9 |
| BMI (kg/m2)a | 28.7 ± 5.2 | 29.5 ± 5.7 | 28.0 ± 4.8 | 28.3 ± 5.4 | 29.9 ± 4.9 |
| EF before rehabilitation (%)b | 30 (28–40) | 35 (30–43) | 30 (25–35) | 35 (30–41) | 25 (19–30)* |
| Dilated cardiomyopathy [n (%)] | 12 (27%) | 5 (24%) | 7 (30%) | 7 (20%) | 5 (50%) |
| Ischemic [n (%)] | 24 (55%) | 11 (52%) | 13 (57%) | 22 (65%) | 2 (20%) |
| Other (valvulopathy, etc) [n (%)] | 8 (18%) | 5 (24%) | 3 (13%) | 5 (15%) | 3 (30%) |
| Diuretics [n (%)] | 29 (66%) | 13 (62%) | 16 (70%) | 20 (59%) | 9 (90%) |
| ACE inhibitors [n (%)] | 22 (50%) | 11 (52%) | 11 (48%) | 18 (53%) | 4 (40%) |
| ARBs [n (%)] | 5 (11%) | 4 (19%) | 1 (4%) | 3 (9%) | 2 (20%) |
| b Blockers [n (%)] | 43 (98%) | 21 (100%) | 22 (96%) | 33 (97%) | 10 (100%) |
| Aldosterone Antagonists [n(%)] | 32 (73%) | 16 (76%) | 16 (70%) | 27 (79%) | 5 (50%) |
| VO2 peak (ml/kg/min)a | 18.4 ± 4.4 | 18.7 ± 5.0 | 18.2 ± 3.8 | 18.9 ± 4.1 | 16.8 ± 5.1 |
| VO2 peak predicted (%)a | 64 ± 15 | 64 ± 19 | 65 ± 12 | 66 ± 14 | 57 ± 19 |
| Peak WR (watts)a | 101 ± 39 | 106 ± 43 | 96 ± 35 | 103 ± 38 | 95 ± 43 |
| CHF, chronic heart failure; HIIT group, high-intensity interval training group; COM group, HIIT combined with muscle strength group; NYHA, New York Heart Association; BMI, body mass index; EF, ejection fraction; ACE, angiotensin-converting-enzyme; ARB, angiotensin II receptor blockers; VO2, oxygen uptake; WR, work rate.a Values are expressed as mean ± SDb Values are expressed as median (25th − 75th percentiles) | |||||
Endothelial cellular populations before and after each symptom-limited maximal cardiopulmonary exercise testing in patients with chronic heart failure.
| Endothelial cellular populationsa,# | Before CR program | After CR program | p value between baseline values | p value for the acute response between CPETs | ||
|---|---|---|---|---|---|---|
| Before CPET | After CPET | Before CPET | After CPET | |||
| 46 (23–74) | 90 (42–106)** | 93 (54–118) | 145 (102–192)** | |||
| 2 (1–3) | 5 (3–8)** | 6 (4–8) | 15 (10–19)** | |||
| 12 (7–18) | 13 (9–19)* | 22 (15–39) | 27 (17–49)* | 0.441 | ||
| 208 (147–266) | 352 (245–569)** | 437 (302–695) | 739 (525–976)** | |||
| 1 (1–2) | 4 (2–5)** | 5 (3–8) | 10 (9–15)** | |||
CR, cardiac rehabilitation; CPET, cardiopulmonary exercise testing.
a Values are presented as median (25th − 75th percentiles)
# Values are expressed as cells/106 enucleated cells
Significant difference in the acute mobilization of cellular populations before and after CPET (*p < 0.05, **p < 0.001)
Fig. 1Numeric mobilization of each circulating endothelial population in 44 patients with chronic heart failure at 4 time points; before and after the initial (CPET 1) and the final (CPET 2) maximal cardiopulmonary exercise testing. Asterisk (*) indicates significant difference in the acute mobilization of circulating endothelial populations after CPET (p < 0.05), cross (†) indicates the increase in the acute response of circulating endothelial populations to maximum exercise after the cardiac rehabilitation program (p < 0.05) while double cross (‡) indicates significant difference in the mobilization of circulating endothelial populations at rest (p < 0.05).
Baseline values (at rest) in variables of each exercise training group before and after a cardiac rehabilitation program.
| Variables of the CR program | HIIT Group (21 patients) | COM Group (23 patients) | p value between groups | ||
|---|---|---|---|---|---|
| CD34+/CD45-/CD133+ | 52 (37–73) | 98 (75–125)** | 41 (21–75) | 89 (46–102)*** | 0.390 |
| CD34+/CD45-/CD133+/VEGFR2 | 2 (1–2) | 6 (5–8)*** | 2 (1–4) | 4 (3–8)*** | 0.439 |
| CD34+/CD133+/VEGFR2 | 10 (7–16) | 22 (14–39)* | 14 (8–18) | 24 (15–40)** | 0.573 |
| CD34+/CD45-/CD133- | 231 (142–279) | 406 (293–690)*** | 202 (148–248) | 520 (356–701)** | 0.472 |
| CD34+/CD45-/CD133-/VEGFR2 | 1 (1–2) | 4 (3–8)*** | 1 (1–3) | 5 (3–8)** | 0.319 |
| Peak VO2 (ml/kg/min) | 18.7 ± 5.0 | 21.8 ± 7.1** | 18.2 ± 3.8 | 19.8 ± 4.1 | 0.295 |
| Predicted peak VO2 (%) | 64 ± 19 | 75 ± 27** | 65 ± 12 | 71 ± 16* | 0.342 |
| Peak WR (watts) | 106 ± 43 | 125 ± 46*** | 96 ± 35 | 116 ± 44*** | 0.839 |
| CRP (mg/dL) | 0.2 (0.1–0.5) | 0.1 (0–0.2)** | 0.2 (0.1–0.5) | 0.1 (0–0.3)** | 0.347 |
| VEGF (pg/ml) | 14 (13–19) | 22 (16–45)*** | 15 (12–20) | 25 (18–39)*** | 0.473 |
HIIT group, high-intensity interval training group; COM group, HIIT combined with muscle strength group; CR, cardiac rehabilitation; Peak VO2, peak oxygen uptake; Peak predicted VO2, predicted peak oxygen uptake; Peak WR, peak work rate; CRP, C-reactive protein; VEGF, vascular endothelial growth factor.
a Values are presented as median (25th − 75th percentiles)
b Values are presented as mean ± SD
# Values are expressed as cells/106 enucleated cells
Significant difference in variables of patients within each exercise group at rest before and after a CR program (*p < 0.05, **p < 0.01, ***p < 0.001)
Fig. 2Numeric value of acute response after maximal cardiopulmonary exercise testing of each circulating endothelial population in HIIT and COM groups at 2 time points; before (acute response 1) and after (acute response 2) the cardiac rehabilitation program. Asterisk (*) indicates significant difference (p < 0.05) within each exercise training group. No difference was observed between the 2 exercise training groups (p > 0.05).
Circulating endothelial populations, CRP and VEGF before and after each symptom-limited maximal cardiopulmonary exercise testing in NYHA II and NYHA III groups before and after a cardiac rehabilitation program.
| Variables of the CR program | NYHA II Group (34 patients) | NYHA III Group (10 patients) | p value | p value | p value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Before CR program | After CR program | Before CR program | After CR program | ||||||||
| Before CPET | After CPET | Before CPET | After CPET | Before CPET | After CPET | Before CPET | After CPET | ||||
| EPC1 | 54 (27–76) | 90 (47–118)* | 96 (69–119)† | 147 (102–172)* | 33 (18–53) | 78 (33–94)* | 69 (43–110)† | 125 (102–261)* ,‡ | 0.307 | 0.079 | |
| EPC2 | 2 (1–3) | 5 (3–8)* | 6 (3–8)† | 15 (11–19)*,‡ | 3 (1–4) | 5 (3–8)* | 6 (4–9)† | 12 (8–15)* | 0.413 | 0.774 | 0.672 |
| EPC3 | 11 (7–18) | 13 (9–21)* | 21 (14–41)† | 24 (17–51)* | 13 (9–26) | 14 (10–18) | 22 (20–38) | 29 (23–52) | 0.906 | 0.299 | |
| CEC1 | 228 (150–274) | 411 (269–591)* | 436 (309–622)† | 722 (516–924)* | 174 (126–273) | 232 (186–515)* | 584 (281–867)† | 926 (664–1647) | 0.338 | 0.111 | |
| CEC2 | 1 (1–2) | 3 (3–5)* | 4 (3–8)† | 10 (9–13)*,‡ | 1 (1–2) | 5 (2–8)* | 6 (3–8)† | 15 (9–20)* ,‡ | 0.229 | 0.178 | 0.563 |
| CRP (mg/dL) | 0.2 (0.1–0.4) | 0.2 (0.1–0.4) | 0.1 (0–0.2)† | 0.1 (0.1–0.3)* | 0.4 (0.2–0.6) | 0.3 (0.2–0.6) | 0.1 (0.1–0.3)† | 0.3 (0.1–0.3) | 0.948 | 0.553 | 0.836 |
| VEGF (pg/ml) | 14 (13–18) | 21 (18–27)* | 22 (17–32)† | 32 (22–47) | 17 (12–36) | 21 (15–29) | 26 (18–70)† | 22 (18–35) | 0.185 | 0.448 | 0.430 |
CR, cardiac rehabilitation; CPET, cardiopulmonary exercise testing; NYHA, New York Heart Association; EPC1, CD34+/CD45-/CD133+; EPC2, CD34+/CD45-/CD133+/VEGFR2; EPC3, CD34+/CD133+/VEGFR2; CEC1, CD34+/CD45-/CD133-; CEC2, CD34+/CD45-/CD133-/VEGFR2; CRP, C-reactive protein; VEGF, vascular endothelial growth factor.
a Values are presented as median (25th − 75th percentiles)
# Values are expressed as cells/106 enucleated cells
* Significant difference in variables before and after CPET within each NYHA class group (p < 0.05)
† Significant difference in variables between baseline values at rest before and after CR within each NYHA class group (p < 0.05)
‡ Significant difference in the acute response of EPCs and CECs between the initial and the final CPET within each NYHA class group (p < 0.05)
| Circulating Endothelial Cells | |
| Chronic Heart Failure | |
| High-intensity interval training combined with muscle strength training | |
| Cardiopulmonary Exercise Testing | |
| Cardiac rehabilitation | |
| C-reactive protein | |
| Electrocardiogram | |
| Ethylenediaminetetraacetic Acid | |
| Ejection Fraction | |
| Endothelial Progenitor Cells | |
| High-intensity interval training | |
| Nitric Oxide | |
| New York Heart Association | |
| Peak oxygen uptake | |
| Peak work rate | |
| Predicted peak oxygen uptake | |
| Standard deviation | |
| Stromal Cell-Derived Factor 1 | |
| Vascular Endothelial Growth Factor | |
| Oxygen Uptake |